Literature DB >> 28517914

Osimertinib in EGFR T790M-Positive Lung Cancer.

Mizuki Nishino1,2, Hiroto Hatabu1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28517914     DOI： 10.1056/NEJMc1703339

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series.

Authors:  Paul Zarogoulidis; Aggeliki Rapti; Chrysanthi Sardeli; Panagiotis Chinelis; Anastasia Athanasiadou; Katerina Paraskevaidou; Anastasios Kallianos; Lemonia Veletza; Georgia Trakada; Wolfgang Hohenforst-Schmidt; Haidong Huang
Journal:  Respir Med Case Rep       Date:  2017-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.